* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
DNA Heparanase (HPSE1) Protein 13 nM (reported value)Salt Solution: 100 mM NaCl, 20 mM KCl, 5 mM MgCl2N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.Selected in the presence of 3.0 M NaSCN.
No inhibitory effect on heparanase activity was observed.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Simmons, SC, et al. Development of novel single-stranded nucleic acid aptamers against the pro-angiogenic and metastatic enzyme heparanase (HPSE1). PLoS One (2012) 7:e37938.
Have your aptamer oligo synthesized by one of our AFFILIATES
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
DNA
Heparanase (HPSE1)
Protein
13 nM (reported value)
Salt Solution: 100 mM NaCl, 20 mM KCl, 5 mM MgCl2
N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Selected in the presence of 3.0 M NaSCN. 
